Betrixaban for VTE Prevention in the Medically Ill Population, the APEX Trial: Good News for This Needy Population?
Ramacciotti, Eduardo; Hoppensteadt, Debra; Fareed, Jawed.
Clin Appl Thromb Hemost
; 23(7): 701-702, 2017 10.
Artigo em Inglês | MEDLINE | ID: mdl-28294628
Pentasaccharides for the prevention of venous thromboembolism.
Neuromuscular electrical stimulation for the prevention of venous thromboembolism.
Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction).
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism.
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization.
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.
Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.
Direct oral anticoagulants for extended-duration thromboprophylaxis in hospitalized medically ill patients: are we there yet?
Individualized Venous Thromboembolism Risk Stratification Using the 2005 Caprini Score to Identify the Benefits and Harms of Chemoprophylaxis in Surgical Patients: A Meta-analysis.